Brivanib alaninate (INN/USAN) also known as BMS-582664 is an investigational, anti-tumorigenic drug for oral administration. The drug is being developed...
12 KB (1,277 words) - 07:01, 2 December 2023
(BMS-791325) – phase III BMS-906024 – phase I BMS-955176 – phase II Brivanib alaninate (BMS-582664) – development terminated Elotuzumab (BMS-901608) – phase...
96 KB (7,620 words) - 18:19, 2 October 2024
Briobacept (USAN, INN) Brioschi Bristacycline Bristagen Bristamycin Brivanib alaninate (USAN, INN) Brivaracetam (USAN, INN) Brivlera brivudine (INN) Brixadi...
6 KB (333 words) - 02:39, 1 July 2024